Pharma & Healthcare
Avastin Biosimilar - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Nov 05, 24
- ID: 660544
- Pages: 89
- Figures: 187
- Views: 7
Avastin Biosimilar is a humanized monoclonal antibody. It inhibits angiogenesis (the formation of new blood vessels) by blocking the action of vascular endothelial growth factor A (VEGF-A). Bevacizumab can therefore slow the growth of new blood vessels in tumours and is used to treat various cancers, including colorectal, lung, breast, glioblastoma, kidney and ovarian.
The global market for Avastin Biosimilar was estimated to be worth US$ 1341 million in 2023 and is forecast to a readjusted size of US$ 471.5 million by 2030 with a CAGR of -14.5% during the forecast period 2024-2030
North American market for Avastin Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Avastin Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Avastin Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Avastin Biosimilar include Celltrion, Amneal, Pfizer and Amgen, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Avastin Biosimilar, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Avastin Biosimilar by region & country, by Type, and by Application.
The Avastin Biosimilar market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Avastin Biosimilar.
Market Segmentation
By Company
Celltrion
Amneal
Pfizer
Amgen
Segment by Type:
400mg
100mg
Segment by Application
Cancer
Wet Age-related Macular Degeneration
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Avastin Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Avastin Biosimilar in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Avastin Biosimilar in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Avastin Biosimilar was estimated to be worth US$ 1341 million in 2023 and is forecast to a readjusted size of US$ 471.5 million by 2030 with a CAGR of -14.5% during the forecast period 2024-2030
North American market for Avastin Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Avastin Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Avastin Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Avastin Biosimilar include Celltrion, Amneal, Pfizer and Amgen, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Avastin Biosimilar, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Avastin Biosimilar by region & country, by Type, and by Application.
The Avastin Biosimilar market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Avastin Biosimilar.
Market Segmentation
By Company
Celltrion
Amneal
Pfizer
Amgen
Segment by Type:
400mg
100mg
Segment by Application
Cancer
Wet Age-related Macular Degeneration
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Avastin Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Avastin Biosimilar in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Avastin Biosimilar in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Avastin Biosimilar Product Introduction
1.2 Global Avastin Biosimilar Market Size Forecast
1.2.1 Global Avastin Biosimilar Sales Value (2019-2030)
1.2.2 Global Avastin Biosimilar Sales Volume (2019-2030)
1.2.3 Global Avastin Biosimilar Sales Price (2019-2030)
1.3 Avastin Biosimilar Market Trends & Drivers
1.3.1 Avastin Biosimilar Industry Trends
1.3.2 Avastin Biosimilar Market Drivers & Opportunity
1.3.3 Avastin Biosimilar Market Challenges
1.3.4 Avastin Biosimilar Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Avastin Biosimilar Players Revenue Ranking (2023)
2.2 Global Avastin Biosimilar Revenue by Company (2019-2024)
2.3 Global Avastin Biosimilar Players Sales Volume Ranking (2023)
2.4 Global Avastin Biosimilar Sales Volume by Company Players (2019-2024)
2.5 Global Avastin Biosimilar Average Price by Company (2019-2024)
2.6 Key Manufacturers Avastin Biosimilar Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Avastin Biosimilar Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Avastin Biosimilar
2.9 Avastin Biosimilar Market Competitive Analysis
2.9.1 Avastin Biosimilar Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Avastin Biosimilar Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avastin Biosimilar as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 400mg
3.1.2 100mg
3.2 Global Avastin Biosimilar Sales Value by Type
3.2.1 Global Avastin Biosimilar Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Avastin Biosimilar Sales Value, by Type (2019-2030)
3.2.3 Global Avastin Biosimilar Sales Value, by Type (%) (2019-2030)
3.3 Global Avastin Biosimilar Sales Volume by Type
3.3.1 Global Avastin Biosimilar Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Avastin Biosimilar Sales Volume, by Type (2019-2030)
3.3.3 Global Avastin Biosimilar Sales Volume, by Type (%) (2019-2030)
3.4 Global Avastin Biosimilar Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cancer
4.1.2 Wet Age-related Macular Degeneration
4.1.3 Other
4.2 Global Avastin Biosimilar Sales Value by Application
4.2.1 Global Avastin Biosimilar Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Avastin Biosimilar Sales Value, by Application (2019-2030)
4.2.3 Global Avastin Biosimilar Sales Value, by Application (%) (2019-2030)
4.3 Global Avastin Biosimilar Sales Volume by Application
4.3.1 Global Avastin Biosimilar Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Avastin Biosimilar Sales Volume, by Application (2019-2030)
4.3.3 Global Avastin Biosimilar Sales Volume, by Application (%) (2019-2030)
4.4 Global Avastin Biosimilar Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Avastin Biosimilar Sales Value by Region
5.1.1 Global Avastin Biosimilar Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Avastin Biosimilar Sales Value by Region (2019-2024)
5.1.3 Global Avastin Biosimilar Sales Value by Region (2025-2030)
5.1.4 Global Avastin Biosimilar Sales Value by Region (%), (2019-2030)
5.2 Global Avastin Biosimilar Sales Volume by Region
5.2.1 Global Avastin Biosimilar Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Avastin Biosimilar Sales Volume by Region (2019-2024)
5.2.3 Global Avastin Biosimilar Sales Volume by Region (2025-2030)
5.2.4 Global Avastin Biosimilar Sales Volume by Region (%), (2019-2030)
5.3 Global Avastin Biosimilar Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Avastin Biosimilar Sales Value, 2019-2030
5.4.2 North America Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Avastin Biosimilar Sales Value, 2019-2030
5.5.2 Europe Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Avastin Biosimilar Sales Value, 2019-2030
5.6.2 Asia Pacific Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Avastin Biosimilar Sales Value, 2019-2030
5.7.2 South America Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Avastin Biosimilar Sales Value, 2019-2030
5.8.2 Middle East & Africa Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Avastin Biosimilar Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Avastin Biosimilar Sales Value
6.2.1 Key Countries/Regions Avastin Biosimilar Sales Value, 2019-2030
6.2.2 Key Countries/Regions Avastin Biosimilar Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Avastin Biosimilar Sales Value, 2019-2030
6.3.2 United States Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Avastin Biosimilar Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Avastin Biosimilar Sales Value, 2019-2030
6.4.2 Europe Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Avastin Biosimilar Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Avastin Biosimilar Sales Value, 2019-2030
6.5.2 China Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
6.5.3 China Avastin Biosimilar Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Avastin Biosimilar Sales Value, 2019-2030
6.6.2 Japan Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Avastin Biosimilar Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Avastin Biosimilar Sales Value, 2019-2030
6.7.2 South Korea Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Avastin Biosimilar Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Avastin Biosimilar Sales Value, 2019-2030
6.8.2 Southeast Asia Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Avastin Biosimilar Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Avastin Biosimilar Sales Value, 2019-2030
6.9.2 India Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
6.9.3 India Avastin Biosimilar Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Celltrion
7.1.1 Celltrion Company Information
7.1.2 Celltrion Introduction and Business Overview
7.1.3 Celltrion Avastin Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Celltrion Avastin Biosimilar Product Offerings
7.1.5 Celltrion Recent Development
7.2 Amneal
7.2.1 Amneal Company Information
7.2.2 Amneal Introduction and Business Overview
7.2.3 Amneal Avastin Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Amneal Avastin Biosimilar Product Offerings
7.2.5 Amneal Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Information
7.3.2 Pfizer Introduction and Business Overview
7.3.3 Pfizer Avastin Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Pfizer Avastin Biosimilar Product Offerings
7.3.5 Pfizer Recent Development
7.4 Amgen
7.4.1 Amgen Company Information
7.4.2 Amgen Introduction and Business Overview
7.4.3 Amgen Avastin Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Amgen Avastin Biosimilar Product Offerings
7.4.5 Amgen Recent Development
8 Industry Chain Analysis
8.1 Avastin Biosimilar Industrial Chain
8.2 Avastin Biosimilar Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Avastin Biosimilar Sales Model
8.5.2 Sales Channel
8.5.3 Avastin Biosimilar Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Avastin Biosimilar Product Introduction
1.2 Global Avastin Biosimilar Market Size Forecast
1.2.1 Global Avastin Biosimilar Sales Value (2019-2030)
1.2.2 Global Avastin Biosimilar Sales Volume (2019-2030)
1.2.3 Global Avastin Biosimilar Sales Price (2019-2030)
1.3 Avastin Biosimilar Market Trends & Drivers
1.3.1 Avastin Biosimilar Industry Trends
1.3.2 Avastin Biosimilar Market Drivers & Opportunity
1.3.3 Avastin Biosimilar Market Challenges
1.3.4 Avastin Biosimilar Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Avastin Biosimilar Players Revenue Ranking (2023)
2.2 Global Avastin Biosimilar Revenue by Company (2019-2024)
2.3 Global Avastin Biosimilar Players Sales Volume Ranking (2023)
2.4 Global Avastin Biosimilar Sales Volume by Company Players (2019-2024)
2.5 Global Avastin Biosimilar Average Price by Company (2019-2024)
2.6 Key Manufacturers Avastin Biosimilar Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Avastin Biosimilar Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Avastin Biosimilar
2.9 Avastin Biosimilar Market Competitive Analysis
2.9.1 Avastin Biosimilar Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Avastin Biosimilar Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avastin Biosimilar as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 400mg
3.1.2 100mg
3.2 Global Avastin Biosimilar Sales Value by Type
3.2.1 Global Avastin Biosimilar Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Avastin Biosimilar Sales Value, by Type (2019-2030)
3.2.3 Global Avastin Biosimilar Sales Value, by Type (%) (2019-2030)
3.3 Global Avastin Biosimilar Sales Volume by Type
3.3.1 Global Avastin Biosimilar Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Avastin Biosimilar Sales Volume, by Type (2019-2030)
3.3.3 Global Avastin Biosimilar Sales Volume, by Type (%) (2019-2030)
3.4 Global Avastin Biosimilar Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cancer
4.1.2 Wet Age-related Macular Degeneration
4.1.3 Other
4.2 Global Avastin Biosimilar Sales Value by Application
4.2.1 Global Avastin Biosimilar Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Avastin Biosimilar Sales Value, by Application (2019-2030)
4.2.3 Global Avastin Biosimilar Sales Value, by Application (%) (2019-2030)
4.3 Global Avastin Biosimilar Sales Volume by Application
4.3.1 Global Avastin Biosimilar Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Avastin Biosimilar Sales Volume, by Application (2019-2030)
4.3.3 Global Avastin Biosimilar Sales Volume, by Application (%) (2019-2030)
4.4 Global Avastin Biosimilar Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Avastin Biosimilar Sales Value by Region
5.1.1 Global Avastin Biosimilar Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Avastin Biosimilar Sales Value by Region (2019-2024)
5.1.3 Global Avastin Biosimilar Sales Value by Region (2025-2030)
5.1.4 Global Avastin Biosimilar Sales Value by Region (%), (2019-2030)
5.2 Global Avastin Biosimilar Sales Volume by Region
5.2.1 Global Avastin Biosimilar Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Avastin Biosimilar Sales Volume by Region (2019-2024)
5.2.3 Global Avastin Biosimilar Sales Volume by Region (2025-2030)
5.2.4 Global Avastin Biosimilar Sales Volume by Region (%), (2019-2030)
5.3 Global Avastin Biosimilar Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Avastin Biosimilar Sales Value, 2019-2030
5.4.2 North America Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Avastin Biosimilar Sales Value, 2019-2030
5.5.2 Europe Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Avastin Biosimilar Sales Value, 2019-2030
5.6.2 Asia Pacific Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Avastin Biosimilar Sales Value, 2019-2030
5.7.2 South America Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Avastin Biosimilar Sales Value, 2019-2030
5.8.2 Middle East & Africa Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Avastin Biosimilar Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Avastin Biosimilar Sales Value
6.2.1 Key Countries/Regions Avastin Biosimilar Sales Value, 2019-2030
6.2.2 Key Countries/Regions Avastin Biosimilar Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Avastin Biosimilar Sales Value, 2019-2030
6.3.2 United States Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Avastin Biosimilar Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Avastin Biosimilar Sales Value, 2019-2030
6.4.2 Europe Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Avastin Biosimilar Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Avastin Biosimilar Sales Value, 2019-2030
6.5.2 China Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
6.5.3 China Avastin Biosimilar Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Avastin Biosimilar Sales Value, 2019-2030
6.6.2 Japan Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Avastin Biosimilar Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Avastin Biosimilar Sales Value, 2019-2030
6.7.2 South Korea Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Avastin Biosimilar Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Avastin Biosimilar Sales Value, 2019-2030
6.8.2 Southeast Asia Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Avastin Biosimilar Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Avastin Biosimilar Sales Value, 2019-2030
6.9.2 India Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
6.9.3 India Avastin Biosimilar Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Celltrion
7.1.1 Celltrion Company Information
7.1.2 Celltrion Introduction and Business Overview
7.1.3 Celltrion Avastin Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Celltrion Avastin Biosimilar Product Offerings
7.1.5 Celltrion Recent Development
7.2 Amneal
7.2.1 Amneal Company Information
7.2.2 Amneal Introduction and Business Overview
7.2.3 Amneal Avastin Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Amneal Avastin Biosimilar Product Offerings
7.2.5 Amneal Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Information
7.3.2 Pfizer Introduction and Business Overview
7.3.3 Pfizer Avastin Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Pfizer Avastin Biosimilar Product Offerings
7.3.5 Pfizer Recent Development
7.4 Amgen
7.4.1 Amgen Company Information
7.4.2 Amgen Introduction and Business Overview
7.4.3 Amgen Avastin Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Amgen Avastin Biosimilar Product Offerings
7.4.5 Amgen Recent Development
8 Industry Chain Analysis
8.1 Avastin Biosimilar Industrial Chain
8.2 Avastin Biosimilar Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Avastin Biosimilar Sales Model
8.5.2 Sales Channel
8.5.3 Avastin Biosimilar Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Avastin Biosimilar Market Trends
Table 2. Avastin Biosimilar Market Drivers & Opportunity
Table 3. Avastin Biosimilar Market Challenges
Table 4. Avastin Biosimilar Market Restraints
Table 5. Global Avastin Biosimilar Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Avastin Biosimilar Revenue Market Share by Company (2019-2024)
Table 7. Global Avastin Biosimilar Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Avastin Biosimilar Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Avastin Biosimilar Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Avastin Biosimilar Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Avastin Biosimilar Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Avastin Biosimilar
Table 13. Global Avastin Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avastin Biosimilar as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Avastin Biosimilar Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Avastin Biosimilar Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Avastin Biosimilar Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Avastin Biosimilar Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Avastin Biosimilar Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Avastin Biosimilar Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Avastin Biosimilar Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Avastin Biosimilar Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Avastin Biosimilar Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Avastin Biosimilar Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Avastin Biosimilar Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Avastin Biosimilar Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Avastin Biosimilar Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Avastin Biosimilar Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Avastin Biosimilar Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Avastin Biosimilar Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Avastin Biosimilar Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Avastin Biosimilar Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Avastin Biosimilar Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Avastin Biosimilar Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Avastin Biosimilar Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Avastin Biosimilar Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Avastin Biosimilar Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Avastin Biosimilar Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Avastin Biosimilar Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Avastin Biosimilar Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Avastin Biosimilar Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Avastin Biosimilar Sales Value by Region (2019-2024) & (%)
Table 44. Global Avastin Biosimilar Sales Value by Region (2025-2030) & (%)
Table 45. Global Avastin Biosimilar Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Avastin Biosimilar Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Avastin Biosimilar Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Avastin Biosimilar Sales Volume by Region (2019-2024) & (%)
Table 49. Global Avastin Biosimilar Sales Volume by Region (2025-2030) & (%)
Table 50. Global Avastin Biosimilar Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Avastin Biosimilar Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Avastin Biosimilar Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Avastin Biosimilar Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Avastin Biosimilar Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Avastin Biosimilar Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Avastin Biosimilar Sales Volume, (2025-2030) & (K Units)
Table 57. Celltrion Company Information
Table 58. Celltrion Introduction and Business Overview
Table 59. Celltrion Avastin Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Celltrion Avastin Biosimilar Product Offerings
Table 61. Celltrion Recent Development
Table 62. Amneal Company Information
Table 63. Amneal Introduction and Business Overview
Table 64. Amneal Avastin Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Amneal Avastin Biosimilar Product Offerings
Table 66. Amneal Recent Development
Table 67. Pfizer Company Information
Table 68. Pfizer Introduction and Business Overview
Table 69. Pfizer Avastin Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Pfizer Avastin Biosimilar Product Offerings
Table 71. Pfizer Recent Development
Table 72. Amgen Company Information
Table 73. Amgen Introduction and Business Overview
Table 74. Amgen Avastin Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Amgen Avastin Biosimilar Product Offerings
Table 76. Amgen Recent Development
Table 77. Key Raw Materials Lists
Table 78. Raw Materials Key Suppliers Lists
Table 79. Avastin Biosimilar Downstream Customers
Table 80. Avastin Biosimilar Distributors List
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Avastin Biosimilar Product Picture
Figure 2. Global Avastin Biosimilar Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Avastin Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Avastin Biosimilar Sales Volume (2019-2030) & (K Units)
Figure 5. Global Avastin Biosimilar Sales Price (2019-2030) & (US$/Unit)
Figure 6. Avastin Biosimilar Report Years Considered
Figure 7. Global Avastin Biosimilar Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Avastin Biosimilar Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Avastin Biosimilar Revenue in 2023
Figure 10. Avastin Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. 400mg Picture
Figure 12. 100mg Picture
Figure 13. Global Avastin Biosimilar Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Avastin Biosimilar Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Avastin Biosimilar Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Avastin Biosimilar Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Avastin Biosimilar Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Cancer
Figure 19. Product Picture of Wet Age-related Macular Degeneration
Figure 20. Product Picture of Other
Figure 21. Global Avastin Biosimilar Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Avastin Biosimilar Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Avastin Biosimilar Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Avastin Biosimilar Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Avastin Biosimilar Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Avastin Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Avastin Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Avastin Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Avastin Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Avastin Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Avastin Biosimilar Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Avastin Biosimilar Sales Volume (%), (2019-2030)
Figure 38. United States Avastin Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Avastin Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Avastin Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Avastin Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 44. China Avastin Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 46. China Avastin Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Avastin Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Avastin Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Avastin Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Avastin Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Avastin Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Avastin Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 56. India Avastin Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 58. India Avastin Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 59. Avastin Biosimilar Industrial Chain
Figure 60. Avastin Biosimilar Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Avastin Biosimilar Market Trends
Table 2. Avastin Biosimilar Market Drivers & Opportunity
Table 3. Avastin Biosimilar Market Challenges
Table 4. Avastin Biosimilar Market Restraints
Table 5. Global Avastin Biosimilar Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Avastin Biosimilar Revenue Market Share by Company (2019-2024)
Table 7. Global Avastin Biosimilar Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Avastin Biosimilar Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Avastin Biosimilar Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Avastin Biosimilar Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Avastin Biosimilar Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Avastin Biosimilar
Table 13. Global Avastin Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avastin Biosimilar as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Avastin Biosimilar Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Avastin Biosimilar Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Avastin Biosimilar Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Avastin Biosimilar Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Avastin Biosimilar Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Avastin Biosimilar Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Avastin Biosimilar Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Avastin Biosimilar Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Avastin Biosimilar Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Avastin Biosimilar Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Avastin Biosimilar Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Avastin Biosimilar Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Avastin Biosimilar Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Avastin Biosimilar Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Avastin Biosimilar Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Avastin Biosimilar Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Avastin Biosimilar Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Avastin Biosimilar Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Avastin Biosimilar Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Avastin Biosimilar Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Avastin Biosimilar Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Avastin Biosimilar Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Avastin Biosimilar Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Avastin Biosimilar Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Avastin Biosimilar Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Avastin Biosimilar Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Avastin Biosimilar Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Avastin Biosimilar Sales Value by Region (2019-2024) & (%)
Table 44. Global Avastin Biosimilar Sales Value by Region (2025-2030) & (%)
Table 45. Global Avastin Biosimilar Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Avastin Biosimilar Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Avastin Biosimilar Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Avastin Biosimilar Sales Volume by Region (2019-2024) & (%)
Table 49. Global Avastin Biosimilar Sales Volume by Region (2025-2030) & (%)
Table 50. Global Avastin Biosimilar Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Avastin Biosimilar Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Avastin Biosimilar Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Avastin Biosimilar Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Avastin Biosimilar Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Avastin Biosimilar Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Avastin Biosimilar Sales Volume, (2025-2030) & (K Units)
Table 57. Celltrion Company Information
Table 58. Celltrion Introduction and Business Overview
Table 59. Celltrion Avastin Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Celltrion Avastin Biosimilar Product Offerings
Table 61. Celltrion Recent Development
Table 62. Amneal Company Information
Table 63. Amneal Introduction and Business Overview
Table 64. Amneal Avastin Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Amneal Avastin Biosimilar Product Offerings
Table 66. Amneal Recent Development
Table 67. Pfizer Company Information
Table 68. Pfizer Introduction and Business Overview
Table 69. Pfizer Avastin Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Pfizer Avastin Biosimilar Product Offerings
Table 71. Pfizer Recent Development
Table 72. Amgen Company Information
Table 73. Amgen Introduction and Business Overview
Table 74. Amgen Avastin Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Amgen Avastin Biosimilar Product Offerings
Table 76. Amgen Recent Development
Table 77. Key Raw Materials Lists
Table 78. Raw Materials Key Suppliers Lists
Table 79. Avastin Biosimilar Downstream Customers
Table 80. Avastin Biosimilar Distributors List
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Avastin Biosimilar Product Picture
Figure 2. Global Avastin Biosimilar Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Avastin Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Avastin Biosimilar Sales Volume (2019-2030) & (K Units)
Figure 5. Global Avastin Biosimilar Sales Price (2019-2030) & (US$/Unit)
Figure 6. Avastin Biosimilar Report Years Considered
Figure 7. Global Avastin Biosimilar Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Avastin Biosimilar Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Avastin Biosimilar Revenue in 2023
Figure 10. Avastin Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. 400mg Picture
Figure 12. 100mg Picture
Figure 13. Global Avastin Biosimilar Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Avastin Biosimilar Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Avastin Biosimilar Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Avastin Biosimilar Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Avastin Biosimilar Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Cancer
Figure 19. Product Picture of Wet Age-related Macular Degeneration
Figure 20. Product Picture of Other
Figure 21. Global Avastin Biosimilar Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Avastin Biosimilar Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Avastin Biosimilar Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Avastin Biosimilar Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Avastin Biosimilar Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Avastin Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Avastin Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Avastin Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Avastin Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Avastin Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Avastin Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Avastin Biosimilar Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Avastin Biosimilar Sales Volume (%), (2019-2030)
Figure 38. United States Avastin Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Avastin Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Avastin Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Avastin Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 44. China Avastin Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 46. China Avastin Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Avastin Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Avastin Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Avastin Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Avastin Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Avastin Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Avastin Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 56. India Avastin Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Avastin Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 58. India Avastin Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 59. Avastin Biosimilar Industrial Chain
Figure 60. Avastin Biosimilar Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232